Abstract the present invention relates to a connection includes a agomelatine, or N - [2 - (7-methoxy-1-naphthyl) ethyl] acetamide inhibitory factor, together with inhibitor agent the re absorption of noradrenaline. The invention relates to Medicaments medicines.
展开▼